171 related articles for article (PubMed ID: 28379829)
1. How Men with Prostate Cancer Choose Specialists: A Qualitative Study.
Jiang T; Stillson CH; Pollack CE; Crossette L; Ross M; Radhakrishnan A; Grande D
J Am Board Fam Med; 2017; 30(2):220-229. PubMed ID: 28379829
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
3. Physician visits prior to treatment for clinically localized prostate cancer.
Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
[TBL] [Abstract][Full Text] [Related]
4. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
[TBL] [Abstract][Full Text] [Related]
5. Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.
Radhakrishnan A; Grande D; Mitra N; Bekelman J; Stillson C; Pollack CE
Cancer; 2017 May; 123(6):1027-1034. PubMed ID: 28263389
[TBL] [Abstract][Full Text] [Related]
6. Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
Radhakrishnan A; Subramanian L; Rankin AJ; Fetters MD; Wittmann DA; Ginsburg KB; Hawley ST; Skolarus TA
Ann Fam Med; 2024; 22(1):5-11. PubMed ID: 38253492
[TBL] [Abstract][Full Text] [Related]
7. [Prostate cancer: how do patients choose their treatment?].
Enel C; Matte A; Berchi C; Binquet C; Cormier L; Lejeune C
Bull Cancer; 2013 Mar; 100(3):191-9. PubMed ID: 23500637
[TBL] [Abstract][Full Text] [Related]
8. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
10. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
[TBL] [Abstract][Full Text] [Related]
11. Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?
Underwood W; Orom H; Poch M; West BT; Lantz PM; Chang SS; Fowke JH
Can J Urol; 2010 Oct; 17(5):5346-54. PubMed ID: 20974025
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of Urologists About the Conversational Elements Leading to Treatment Decision-Making Among Newly Diagnosed Prostate Cancer Patients.
Adsul P; Wray R; Boyd D; Weaver N; Siddiqui S
J Cancer Educ; 2017 Sep; 32(3):580-588. PubMed ID: 27029194
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.
Makarov DV; Sedlander E; Braithwaite RS; Sherman SE; Zeliadt S; Gross CP; Curnyn C; Shedlin M
Implement Sci; 2016 Sep; 11(1):118. PubMed ID: 27590603
[TBL] [Abstract][Full Text] [Related]
14. Primary care physicians' use of publicly reported quality data in hospital referral decisions.
Morsi E; Lindenauer PK; Rothberg MB
J Hosp Med; 2012; 7(5):370-5. PubMed ID: 22378738
[TBL] [Abstract][Full Text] [Related]
15. Primary care physician specialty referral decision making: patient, physician, and health care system determinants.
Forrest CB; Nutting PA; von Schrader S; Rohde C; Starfield B
Med Decis Making; 2006; 26(1):76-85. PubMed ID: 16495203
[TBL] [Abstract][Full Text] [Related]
16. Choosing a Specialist: An Explanatory Study of Factors Influencing Patients in Choosing a Urologist.
Tamalunas A; Buchner A; Hennenberg M; Stadelmeier LF; Höhn H; Vilsmaier T; Mumm ML; Kolben T; Stief CG; Mumm JN
Urol Int; 2021; 105(9-10):749-756. PubMed ID: 34274925
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis.
Kandasamy S; Khalid AF; Majid U; Vanstone M
Ont Health Technol Assess Ser; 2017; 17(7):1-32. PubMed ID: 28572868
[TBL] [Abstract][Full Text] [Related]
18. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
[TBL] [Abstract][Full Text] [Related]
19. Navigating healthcare: a qualitative study exploring prostate cancer patients' and doctors' experience of consultations using a decision-support intervention.
Hacking B; Scott SE; Wallace LM; Shepherd SC; Belkora J
Psychooncology; 2014 Jun; 23(6):665-71. PubMed ID: 24677394
[TBL] [Abstract][Full Text] [Related]
20. The evolution of uncertainty in second opinions about prostate cancer treatment.
Hillen MA; Gutheil CM; Smets EMA; Hansen M; Kungel TM; Strout TD; Han PKJ
Health Expect; 2017 Dec; 20(6):1264-1274. PubMed ID: 28521078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
